A record for the reading desk
Cagrilintide
The recorded fields, their references, and a question worth keeping.
- Status
- Investigational
- Evidence label
- Randomized evidence
- Index topics
- Metabolism
- Status as of
Record / 01
Recorded fields
- Mechanism
- A long-acting amylin analogue.
- Evidence
- A randomized weight-management trial was funded by Novo Nordisk.
- Limitations
- Combination results cannot be assigned to a single ingredient.
- Safety
- The trial reported gastrointestinal and injection-site reactions.
- Route context
- Studied as a subcutaneous injection.
- Approval scope
- Investigational; no FDA-approved product.
Reasoning / 02
A note for your reading
When two features move together, it is tempting to draw an arrow from one to the other. Before doing that, consider whether a shared influence could produce both. In a hypothetical record, a common input might account for their association without either feature causing the other. Listing that possibility does not establish it as the explanation. It gives the causal claim a competitor to address. A careful reader can acknowledge the association while asking what additional comparison would help separate the proposed direction of influence from the shared influence.
Keep asking / 03
Three questions to carry forward
- Could a shared influence explain why these features appear together here?
- What comparison would help separate that possibility from the proposed causal direction?
- Which part of the argument supports the direction of the claimed influence?
Trace the record / 04